How much did Align spend on buybacks in Q2 2026?

Align repurchased approximately 393,400 shares at an average price of $169.45 per share, spending approximately $67 million in the second quarter. These purchases were made under a $200 million open-market plan announced in April 2026.

How much buyback authorization remains available?

As of June 30, 2026, $733.3 million remains available under Align's $1.0 billion stock repurchase program announced in April 2025. The company expects the current $200 million plan to be completed by October 2026.

What is Align's full-year 2026 buyback guidance?

Align increased its 2026 buyback guidance to $400–500 million, up from prior expectations. This includes approximately $133 million expected to be repurchased through October 2026. Management characterized this increase as reflecting conviction in the company's long-term value creation.

How do buybacks fit into Align's capital allocation strategy?

Align balances buybacks with investments in innovation, customer support, and manufacturing capacity expansion. The company generated strong operating cash flow and maintains over $1.1 billion in cash, providing flexibility to fund growth while returning capital to shareholders through open-market repurchases.

What method does Align use to execute its buybacks?

Align executes buybacks via Rule 10b-18 open-market purchases, which provide a standardized safe-harbor framework for repurchases and allow the company flexibility to manage repurchase timing and volume in response to market conditions.

ALGN 8-K Filed 2026-07-29 Execution disclosure

Align Technology repurchased 0.4M shares in Q2 at $169.45 average

Medical device maker executed $67M in buybacks during quarter; $733.3M remains under authorization

Shares repurchased393K

Avg price paid$169.45

Remaining$733M

MechanismRule 10b-18 open-market purcha

What the filing says

Align Technology repurchased approximately 393,400 shares of common stock during the second quarter of 2026 at an average price of $169.45 per share, returning approximately $67 million to shareholders. These purchases were conducted pursuant to a $200 million open-market repurchase plan announced on April 29, 2026, which the company expects to complete by October 2026.

As of June 30, 2026, the company had $733.3 million remaining available for repurchases under its $1.0 billion stock repurchase program announced in April 2025. Looking ahead, Align raised its full-year 2026 buyback guidance, now expecting to repurchase $400 million to $500 million of common stock in 2026, which management characterized as reflecting "the conviction of the Board and Management in Align's long-term value."

The Q2 buybacks were executed via Rule 10b-18 open-market purchases. The company maintains a strong balance sheet with $1.1 billion in cash and cash equivalents as of quarter-end, and continues to balance capital allocation between innovation investments, customer support, and shareholder returns.

During Q2'26, we repurchased approximately 393.4 thousand shares of our common stock at an average price of $169.45 per share. These purchases were made pursuant to the $200.0 million open market repurchase plan announced on April 29, 2026, which we expect will be completed in October 2026. — ALIGN TECHNOLOGY INC 8-K filing · View on SEC EDGAR →

What this means

Align's Q2 buyback activity represents steady capital return to shareholders while the company maintains balance-sheet flexibility. At $169.45 per share, the company repurchased shares in line with trading levels during that quarter. With $733.3 million remaining under the $1 billion authorization and raised full-year guidance to $400–500 million in repurchases, management is signaling confidence in the stock's valuation. The buyback program runs alongside the company's core initiatives in clear aligner innovation, scanner adoption, and geographic expansion; combined with healthy operating cash flow generation, the program demonstrates that Align believes it can simultaneously fund growth investments and return capital.

Frequently asked questions

How much did Align spend on buybacks in Q2 2026?: Align repurchased approximately 393,400 shares at an average price of $169.45 per share, spending approximately $67 million in the second quarter. These purchases were made under a $200 million open-market plan announced in April 2026.
How much buyback authorization remains available?: As of June 30, 2026, $733.3 million remains available under Align's $1.0 billion stock repurchase program announced in April 2025. The company expects the current $200 million plan to be completed by October 2026.
What is Align's full-year 2026 buyback guidance?: Align increased its 2026 buyback guidance to $400–500 million, up from prior expectations. This includes approximately $133 million expected to be repurchased through October 2026. Management characterized this increase as reflecting conviction in the company's long-term value creation.
How do buybacks fit into Align's capital allocation strategy?: Align balances buybacks with investments in innovation, customer support, and manufacturing capacity expansion. The company generated strong operating cash flow and maintains over $1.1 billion in cash, providing flexibility to fund growth while returning capital to shareholders through open-market repurchases.
What method does Align use to execute its buybacks?: Align executes buybacks via Rule 10b-18 open-market purchases, which provide a standardized safe-harbor framework for repurchases and allow the company flexibility to manage repurchase timing and volume in response to market conditions.

execution rule-10b-18 medical-devices q2-2026 open-market authorization

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.